tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Danone SA ADR Reports Strong H1 2025 Performance

Danone SA ADR Reports Strong H1 2025 Performance

Danone SA ADR ( (DANOY) ) has released its Q2 earnings. Here is a breakdown of the information Danone SA ADR presented to its investors.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Danone SA ADR is a multinational food-products corporation based in Paris, France, primarily engaged in the production of dairy products, bottled water, and specialized nutrition products. The company is known for its commitment to health-focused offerings and innovation in the food and beverage industry.

In its 2025 half-year earnings report, Danone SA ADR announced a solid performance with a like-for-like sales increase of 4.2%, driven by a 2.6% rise in volume/mix and a 1.7% increase in price. The company also reported a recurring operating margin improvement of 49 basis points, reaching 13.2%, and a recurring EPS growth of 5.8% to €1.91.

Key highlights from the report include a strong performance in the China, North Asia & Oceania region with a 12.4% like-for-like sales growth, and a notable increase in the Specialized Nutrition category, which saw a 7.0% rise. Despite currency fluctuations negatively impacting reported sales, Danone maintained robust operational performance, supported by strategic acquisitions such as Kate Farms and The Akkermansia Company.

Danone’s free cash flow stood at €1.2 billion, reflecting a slight decrease from the previous year, while net debt increased to €9.1 billion due to dividend payments. The company confirmed its 2025 guidance, anticipating like-for-like sales growth between 3% and 5%, with recurring operating income expected to grow faster than sales.

Looking ahead, Danone remains focused on executing its Renew strategy, emphasizing consumer-centric and science-based approaches to drive growth. The company is poised to continue expanding its health-focused portfolio and enhancing its market presence through strategic investments and innovations.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1